Stocks
Atara Biotherapeutics (ATRA) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -282.9 | -296.7 | -331.1 | -213.7 | -266.0 | -125.5 | ||
| Changes by years, y/y, % | +19% | +5% | +12% | -35% | +24% | +2.3% | |||
Atara Biotherapeutics. EBITDA US GAAP, bln rub
Atara Biotherapeutics. EBITDA US GAAP, changes, %
Atara Biotherapeutics. EBITDA US GAAP, sum by quarters, bln rub
Atara Biotherapeutics (ATRA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -67.2 | -58.1 | -29.2 | -16.5 | -21.8 | -125.5 | |
| Changes by years, y/y, % | -19% | -23% | -61% | -76% | -68% | |||
| Changes by quarters, q/q, % | -2% | -14% | -50% | -44% | +32% | |||
